Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocylcer (CODEX) Multiplex Imaging
FY 2022-23
Summary
Triple-negative breast cancer (TNBC) is a devastating diagnosis for patients due to its poor prognosis and the lack of effective therapies. Unlike HER-2 or HR-positive breast cancer, chemotherapy with standard cytotoxic agents is the only systemic treatment option for TNBC. We have previously shown that the chemical modification of the protein eIF4E causes the production of metastasis-producing proteins. Modified eIF4E also affects the surrounding cells around the tumor, called the tumor microenvironment (TME). The TME is the ecosystem that surrounds a tumor and gives the tumor all the nutrients it needs. It includes immune cells, extracellular matrix, blood vessels, fibroblasts. We know that modified eIF4E affects fibroblasts by changing their function to become pro-tumoral cancer-associated fibroblasts (CAFs). CAFs are the architects of the TME; they receive signals from the tumor to remodel the environment around them. We propose that the modification of eIF4E gives CAFs another function in TNBC. CAFs participate in crosstalk with immune cells and recruit macrophages to create an immunosuppressive environment. This environment helps the tumor grow, spread, and metastasize to other organs, such as the lungs. We will test this by imaging mouse and human tumor samples using a Phenocylcer (CODEX) to understand the layout and interactions of CAFs within the TME. The CODEX is a novel imaging technology that allows for simultaneous spatial profiling of over 40 markers on tissue sections. This number of markers was previously impossible with other imaging technologies such as immunofluorescence or immunohistochemistry. Findings from this project may highlight limiting the chemical alteration of eIF4E with existing drugs as a new therapeutic option for TNBC.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
498211
Name
McCallum Paige
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Spatially Profiling the Human Breast Cancer Tissue Tumor Microenvironment using Phenocylcer (CODEX) Multiplex Imaging
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Fibroblasts; Immunofluorescence; Immunology; Metastasis; Mrna; Multiplex Imaging; Signaling Pathwats; Tumor Microenvironment; Tumor-Associated Macrophages
Abstract
Triple-negative breast cancer (TNBC) is a devastating diagnosis for patients due to its poor prognosis and the lack of effective therapies. Unlike HER-2 or HR-positive breast cancer, chemotherapy with standard cytotoxic agents is the only systemic treatment option for TNBC. We have previously shown that the chemical modification of the protein eIF4E causes the production of metastasis-producing proteins. Modified eIF4E also affects the surrounding cells around the tumor, called the tumor microenvironment (TME). The TME is the ecosystem that surrounds a tumor and gives the tumor all the nutrients it needs. It includes immune cells, extracellular matrix, blood vessels, fibroblasts. We know that modified eIF4E affects fibroblasts by changing their function to become pro-tumoral cancer-associated fibroblasts (CAFs). CAFs are the architects of the TME; they receive signals from the tumor to remodel the environment around them. We propose that the modification of eIF4E gives CAFs another function in TNBC. CAFs participate in crosstalk with immune cells and recruit macrophages to create an immunosuppressive environment. This environment helps the tumor grow, spread, and metastasize to other organs, such as the lungs. We will test this by imaging mouse and human tumor samples using a Phenocylcer (CODEX) to understand the layout and interactions of CAFs within the TME. The CODEX is a novel imaging technology that allows for simultaneous spatial profiling of over 40 markers on tissue sections. This number of markers was previously impossible with other imaging technologies such as immunofluorescence or immunohistochemistry. Findings from this project may highlight limiting the chemical alteration of eIF4E with existing drugs as a new therapeutic option for TNBC.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
McCallum, Paige
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~